Original Query: ALL
Previous Study | Return to List | Next Study

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00027261
Recruitment Status : Completed
First Posted : November 30, 2001
Last Update Posted : May 17, 2012
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)